Levitan B - Search Results

1

Current Practices and Challenges When Submitting Patient Experience Data for Regulatory Decisions by the US Food and Drug Administration: An Industry Survey.

Pinto CA, Tervonen T, Jimenez-Moreno C, Levitan B, Soriano Gabarró M, Girman C, Norquist JM, Hauber B. Pinto CA, et al. Among authors: levitan b. Patient. 2024 Mar;17(2):147-159. doi: 10.1007/s40271-023-00653-8. Epub 2023 Dec 12. Patient. 2024. PMID: 38085458 Free PMC article.

2

Trajectories of health care service utilization and differences in patient characteristics among adults with specific chronic pain: analysis of health plan member claims.

Ruetsch C, Tkacz J, Kardel PG, Howe A, Pai H, Levitan B. Ruetsch C, et al. Among authors: levitan b. J Pain Res. 2013;6:137-49. doi: 10.2147/JPR.S38301. Epub 2013 Feb 21. J Pain Res. 2013. PMID: 23459176 Free PMC article.

3

Psychiatrists' judgments about antipsychotic benefit and risk outcomes and formulation in schizophrenia treatment.

Markowitz MA, Levitan BS, Mohamed AF, Johnson FR, Bridges JF, Alphs L, Citrome L. Markowitz MA, et al. Psychiatr Serv. 2014 Sep 1;65(9):1133-9. doi: 10.1176/appi.ps.201300290. Psychiatr Serv. 2014. PMID: 24828964

4

Patients' Preferences Related to Benefits, Risks, and Formulations of Schizophrenia Treatment.

Levitan B, Markowitz M, Mohamed AF, Johnson FR, Alphs L, Citrome L, Bridges JF. Levitan B, et al. Psychiatr Serv. 2015 Jul;66(7):719-26. doi: 10.1176/appi.ps.201400188. Epub 2015 Mar 16. Psychiatr Serv. 2015. PMID: 25772762

5

A model for decision support in signal triage.

Levitan B, Yee CL, Russo L, Bayney R, Thomas AP, Klincewicz SL. Levitan B, et al. Drug Saf. 2008;31(9):727-35. doi: 10.2165/00002018-200831090-00001. Drug Saf. 2008. PMID: 18707187

6

A concise display of multiple end points for benefit-risk assessment.

Levitan B. Levitan B. Clin Pharmacol Ther. 2011 Jan;89(1):56-9. doi: 10.1038/clpt.2010.251. Epub 2010 Nov 24. Clin Pharmacol Ther. 2011. PMID: 21107317 Clinical Trial.

7

Physician and patient benefit-risk preferences from two randomized long-acting injectable antipsychotic trials.

Katz EG, Hauber B, Gopal S, Fairchild A, Pugh A, Weinstein RB, Levitan BS. Katz EG, et al. Among authors: levitan bs. Patient Prefer Adherence. 2016 Oct 21;10:2127-2139. doi: 10.2147/PPA.S114172. eCollection 2016. Patient Prefer Adherence. 2016. PMID: 27799749 Free PMC article.

8

Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review.

Soekhai V, Whichello C, Levitan B, Veldwijk J, Pinto CA, Donkers B, Huys I, van Overbeeke E, Juhaeri J, de Bekker-Grob EW. Soekhai V, et al. Among authors: levitan b. Drug Discov Today. 2019 Jul;24(7):1324-1331. doi: 10.1016/j.drudis.2019.05.001. Epub 2019 May 8. Drug Discov Today. 2019. PMID: 31077814 Free article. Review.

9

Appraising patient preference methods for decision-making in the medical product lifecycle: an empirical comparison.

Whichello C, Levitan B, Juhaeri J, Patadia V, DiSantostefano R, Pinto CA, de Bekker-Grob EW. Whichello C, et al. Among authors: levitan b. BMC Med Inform Decis Mak. 2020 Jun 19;20(1):114. doi: 10.1186/s12911-020-01142-w. BMC Med Inform Decis Mak. 2020. PMID: 32560655 Free PMC article.

10

Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference Study.

Jimenez-Moreno AC, van Overbeeke E, Pinto CA, Smith I, Sharpe J, Ormrod J, Whichello C, de Bekker-Grob EW, Bullok K, Levitan B, Huys I, de Wit GA, Gorman G. Jimenez-Moreno AC, et al. Among authors: levitan b. Patient. 2021 Sep;14(5):601-612. doi: 10.1007/s40271-020-00482-z. Epub 2021 Feb 27. Patient. 2021. PMID: 33660162 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters